UnitedHealth (UNH) Stock Forecast & Price Target

Compare

22,079 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

UNH Analyst Ratings

Moderate Buy

17 Buy

3 Hold

2 Sell

Based on 22 analysts giving stock ratings to

UnitedHealth

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

UNH Stock 12 Month Forecast

Average Price Target

$386.27

▲(13.09% Upside)

Based on 22 Wall Street analysts offering 12 month price targets for UnitedHealth in the last 3 months. The average price target is $386.27 with a high forecast of $440.00 and a low forecast of $198.00. The average price target represents a 13.09% change from the last price of $341.56.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"197":"$197","596":"$596","296.75":"$296.8","396.5":"$396.5","496.25":"$496.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":440,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$440.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":386.27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$386.27</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":198,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$198.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[197,296.75,396.5,496.25,596],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,348.3,355.3538461538462,362.40769230769234,369.46153846153845,376.5153846153846,383.5692307692308,390.62307692307695,397.67692307692306,404.7307692307692,411.7846153846154,418.83846153846156,425.89230769230767,432.94615384615383,{"y":440,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,348.3,351.22076923076924,354.14153846153846,357.0623076923077,359.9830769230769,362.90384615384613,365.8246153846154,368.74538461538464,371.66615384615386,374.5869230769231,377.5076923076923,380.42846153846153,383.34923076923076,{"y":386.27,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,348.3,336.73846153846154,325.17692307692306,313.61538461538464,302.05384615384617,290.4923076923077,278.9307692307692,267.36923076923074,255.80769230769232,244.24615384615385,232.68461538461537,221.12307692307692,209.56153846153845,{"y":198,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":570.92,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":555.51,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":595.6,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":497.02,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 60,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":533.01,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 66,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":466.66,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":516.18,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":395.36,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 64,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":300.68,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 72,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":324.1,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 65,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":236.28,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":306.86,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 53,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":348.3,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 57,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$440.00

Average Price Target$386.27

Lowest Price Target$198.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Lance Wilkes

Bernstein

$433→$440

Buy

28.82%

Upside

Reiterated

10/30/25

Positive Outlook for UnitedHealth: Strong Earnings Recovery and Strategic Positioning in Value-Based CareWe have updated our UNH EPS model post-3Q earnings — we raise our price target to $440 (vs. $433 previously) and remain Outperform.

Soren Coverra

TR | OpenAI - 4o

$410→$401

Buy

17.40%

Upside

Reiterated

10/30/25

AI Generated ArticleAI Generated Article

Ryan Langston

TD Cowen

$335→$338

Hold

-1.04%

Downside

Reiterated

10/30/25

UnitedHealth: Navigating 2026 Challenges with Strategic Growth Plans for a Promising 2027

Erin Wright

Morgan Stanley

$395→$411

Buy

20.33%

Upside

Reiterated

10/29/25

Optimistic Outlook for UnitedHealth: Buy Rating Based on Recovery and Growth Potential

David S Macdonald

Truist Financial

$410

Buy

20.04%

Upside

Reiterated

10/29/25

Truist Financial Remains a Buy on UnitedHealth (UNH)We remain bullish on UNH with an attractive path forward – Reit Buy, $410 PT, model under review.

Michael Wiederhorn

Oppenheimer

$325→$415

Buy

21.50%

Upside

Reiterated

10/29/25

UnitedHealth price target raised to $415 from $325 at OppenheimerUnitedHealth price target raised to $415 from $325 at Oppenheimer

A.J. Rice

UBS

$378→$430

Buy

25.89%

Upside

Reiterated

10/29/25

UnitedHealth price target raised to $430 from $378 at UBSUnitedHealth price target raised to $430 from $378 at UBS

George Hill

Deutsche Bank

$275→$333

Hold

-2.51%

Downside

Downgraded

10/29/25

UnitedHealth downgraded to Hold from Buy at Deutsche BankUnitedHealth downgraded to Hold from Buy at Deutsche Bank

Kevin Fischbeck

Bank of America Securities

$390→$410

Hold

20.04%

Upside

Reiterated

10/29/25

Analysts Offer Insights on Healthcare Companies: Alkermes (NASDAQ: ALKS), Medtronic (NYSE: MDT) and UnitedHealth (NYSE: UNH)

Andrew Mok CFA

Barclays

$386

Buy

13.01%

Upside

Reiterated

10/29/25

Barclays Sticks to Their Buy Rating for UnitedHealth (UNH)

Jessica Tassan

Piper Sandler

$423→$417

Buy

22.09%

Upside

Reiterated

10/29/25

UnitedHealth (UNH) Receives a Buy from Piper Sandler

Ann Hynes

Mizuho Securities

$430

Buy

25.89%

Upside

Reiterated

10/28/25

Mizuho Securities Remains a Buy on UnitedHealth (UNH)Overall, we view the quarter positively and reiterate our Outperform rating.

David Windley

Jefferies

$409

Buy

19.74%

Upside

Reiterated

10/28/25

UnitedHealth Poised for Growth: Buy Rating Affirmed on Strong EPS Outlook and Effective Cost Management

Scott Fidel

Goldman Sachs

$362.5→$406

Buy

18.87%

Upside

Reiterated

10/28/25

UnitedHealth's Strong Financial Performance and Strategic Adjustments Justify Buy Rating

Ben Hendrix

RBC Capital

$286→$408

Buy

19.45%

Upside

Reiterated

10/28/25

Analysts Offer Insights on Healthcare Companies: Gyre Therapeutics (NASDAQ: GYRE), Regeneron (NASDAQ: REGN) and UnitedHealth (NYSE: UNH)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Lance Wilkes

Bernstein

$433→$440

Buy

28.82%

Upside

Reiterated

10/30/25

Soren Coverra

TR | OpenAI - 4o

$410→$401

Buy

17.40%

Upside

Reiterated

10/30/25

AI Generated ArticleAI Generated Article

Ryan Langston

TD Cowen

$335→$338

Hold

-1.04%

Downside

Reiterated

10/30/25

UnitedHealth: Navigating 2026 Challenges with Strategic Growth Plans for a Promising 2027

Erin Wright

Morgan Stanley

$395→$411

Buy

20.33%

Upside

Reiterated

10/29/25

Optimistic Outlook for UnitedHealth: Buy Rating Based on Recovery and Growth Potential

David S Macdonald

Truist Financial

$410

Buy

20.04%

Upside

Reiterated

10/29/25

Truist Financial Remains a Buy on UnitedHealth (UNH)We remain bullish on UNH with an attractive path forward – Reit Buy, $410 PT, model under review.

Michael Wiederhorn

Oppenheimer

$325→$415

Buy

21.50%

Upside

Reiterated

10/29/25

UnitedHealth price target raised to $415 from $325 at OppenheimerUnitedHealth price target raised to $415 from $325 at Oppenheimer

A.J. Rice

UBS

$378→$430

Buy

25.89%

Upside

Reiterated

10/29/25

UnitedHealth price target raised to $430 from $378 at UBSUnitedHealth price target raised to $430 from $378 at UBS

George Hill

Deutsche Bank

$275→$333

Hold

-2.51%

Downside

Downgraded

10/29/25

UnitedHealth downgraded to Hold from Buy at Deutsche BankUnitedHealth downgraded to Hold from Buy at Deutsche Bank

Kevin Fischbeck

Bank of America Securities

$390→$410

Hold

20.04%

Upside

Reiterated

10/29/25

Analysts Offer Insights on Healthcare Companies: Alkermes (NASDAQ: ALKS), Medtronic (NYSE: MDT) and UnitedHealth (NYSE: UNH)

Andrew Mok CFA

Barclays

$386

Buy

13.01%

Upside

Reiterated

10/29/25

Barclays Sticks to Their Buy Rating for UnitedHealth (UNH)

Jessica Tassan

Piper Sandler

$423→$417

Buy

22.09%

Upside

Reiterated

10/29/25

UnitedHealth (UNH) Receives a Buy from Piper Sandler

Ann Hynes

Mizuho Securities

$430

Buy

25.89%

Upside

Reiterated

10/28/25

Mizuho Securities Remains a Buy on UnitedHealth (UNH)Overall, we view the quarter positively and reiterate our Outperform rating.

David Windley

Jefferies

$409

Buy

19.74%

Upside

Reiterated

10/28/25

UnitedHealth Poised for Growth: Buy Rating Affirmed on Strong EPS Outlook and Effective Cost Management

Scott Fidel

Goldman Sachs

$362.5→$406

Buy

18.87%

Upside

Reiterated

10/28/25

UnitedHealth's Strong Financial Performance and Strategic Adjustments Justify Buy Rating

Ben Hendrix

RBC Capital

$286→$408

Buy

19.45%

Upside

Reiterated

10/28/25

Analysts Offer Insights on Healthcare Companies: Gyre Therapeutics (NASDAQ: GYRE), Regeneron (NASDAQ: REGN) and UnitedHealth (NYSE: UNH)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering UnitedHealth

1 Month

xxx

Success Rate

26/35 ratings generated profit

Average Return

+2.46%

reiterated a xxx

rating 24 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 74.29% of your transactions generating a profit, with an average return of +2.46% per trade.

3 Months

xxx

Success Rate

25/35 ratings generated profit

Average Return

+3.95%

reiterated a xxx

rating 24 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +3.95% per trade.

1 Year

Scott FidelGoldman Sachs

Success Rate

35/43 ratings generated profit

Average Return

+21.06%

reiterated a buy rating 6 days ago

Copying Scott Fidel's trades and holding each position for 1 Year would result in 81.40% of your transactions generating a profit, with an average return of +21.06% per trade.

2 Years

xxx

Success Rate

39/44 ratings generated profit

Average Return

+44.42%

assigned a xxx

rating 28 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 88.64% of your transactions generating a profit, with an average return of +44.42% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UNH Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, UNH has received 57 Buy Ratings, 9 Hold Ratings, and 2 Sell Ratings. UNH average Analyst price target in the past 3 months is 386.27.

Each month's total comprises the sum of three months' worth of ratings.

UNH Financial Forecast

UNH Earnings Forecast

Next quarter’s earnings estimate for UNH is $2.09 with a range of $1.64 to $2.86. The previous quarter’s EPS was $2.92. UNH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year UNH has Preformed in-line its overall industry.

UNH Sales Forecast

Next quarter’s sales forecast for UNH is $113.48B with a range of $110.15B to $115.60B. The previous quarter’s sales results were $113.16B. UNH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year UNH has Preformed in-line its overall industry.

UNH Stock Forecast FAQ

What is UNH’s average 12-month price target, according to analysts?

Based on analyst ratings, UnitedHealth’s 12-month average price target is 386.27.

What is UNH’s upside potential, based on the analysts’ average price target?

UnitedHealth has 13.09% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is UNH a Buy, Sell or Hold?

UnitedHealth has a consensus rating of Moderate Buy which is based on 17 buy ratings, 3 hold ratings and 2 sell ratings.

What is UnitedHealth’s price target?

The average price target for UnitedHealth is 386.27. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $440.00 ,the lowest forecast is $198.00. The average price target represents 13.09% Increase from the current price of $341.56.

What do analysts say about UnitedHealth?

UnitedHealth’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 22 Wall Streets Analysts.

How can I buy shares of UNH?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

UnitedHealth (UNH) Stock Forecast & Price Target

UNH Analyst Ratings

UNH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering UnitedHealth

UNH Analyst Recommendation Trends

UNH Financial Forecast

UNH Earnings Forecast

UNH Sales Forecast

UNH Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts